Politico April 8, 2023
By Dan Goldberg

A Texas judge’s preliminary ruling invalidating the FDA’s approval of the abortion pill could make it harder for patients to get abortions even in states where it remains legal.

A federal judge on Friday suspended the FDA’s approval of mifepristone — the most popular method for terminating a pregnancy.

The ruling — as much as any since the Supreme Court overturned Roe v. Wade in June — could upend the national landscape, threatening abortion access for hundreds of thousands of people whether they live in a state that prohibits almost all abortions, such as Texas, or a liberal haven like California.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies, Patient / Consumer, Provider
The risk of a bird flu pandemic is rising
Epidemics then and now: Managing loneliness, burnout, and social media toxicity
Patient Portals 4.0: Future of Patient Engagement
AI tool could predict type 2 diabetes 10 years in advance
208 million Americans are classified as obese or overweight, according to new study on 132 data sources

Share This Article